Targeting pain at its source in sickle cell disease

Keyphrases

• Sickle Cell Disease 100%
• Sickle Cell Pain 75%
• Therapeutic Target 25%
• Adaptation 25%
• Molecular Mechanism 25%
• Neural Circuits 25%
• Opioids 25%
• Genetic Disease 25%
• Chronic Pain 25%
• Neurogenic Inflammation 25%
• Central Nervous System 25%
• Cellular Mechanisms 25%
• Adverse Effects 25%
• Acute Pain 25%
• Hospitalization 25%
• Somatosensory System 25%
• Mast Cell Activation 25%
• Integrative Approach 25%
• Vaso-occlusive Crisis 25%
• Hemolytic Anemia 25%
• Pharmacologic 25%
• End-organ Damage 25%
• Peripheral Nervous System 25%
• Central Sensitization 25%
• Reduced Survival 25%
• Nociceptor Sensitization 25%
• Central Modulation 25%
• Peripheral Nociceptors 25%

Medicine and Dentistry

• Sickle Cell 100%
• Sickle-Cell Disease 100%
• Sensitization 66%
• Pain 33%
• Central Nervous System 33%
• Somatosensory System 33%
• Adverse Event 33%
• Persistent Pain 33%
• Hemolytic Anemia 33%
• Genetic Disorder 33%
• End Organ Damage 33%
• Cell Activation 33%
• Patient with Sickle Cell Disease 33%
• Peripheral Nervous System 33%
• Nociceptor 33%
• Infancy 33%
• Neurogenic Inflammation 33%
• Opiate 33%
• Mast Cell 33%